Supplemental material
Open access
1,617
Views
3
CrossRef citations to date
0
Altmetric
General Xenobiochemistry
A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method
Simon J. CarterBiomedical and Biological Systems Laboratory, School of Engineering, University of Warwick, Coventry, United Kingdom; http://orcid.org/0000-0002-8220-2321View further author information
, Alex S. FerecskóUCB Pharma Ltd, Slough, United Kingdom; http://orcid.org/0000-0001-5947-7661View further author information
, Lloyd KingUCB Pharma Ltd, Slough, United Kingdom; http://orcid.org/0000-0002-3301-7533View further author information
, Karelle MénochetUCB Pharma Ltd, Slough, United Kingdom; http://orcid.org/0000-0002-0055-9870View further author information
, Ted PartonMekinopsis Ltd, London, United Kingdomhttp://orcid.org/0000-0001-6007-9185View further author information
& Michael J. ChappellBiomedical and Biological Systems Laboratory, School of Engineering, University of Warwick, Coventry, United Kingdom; Correspondence[email protected]
http://orcid.org/0000-0003-3619-3150View further author information
http://orcid.org/0000-0003-3619-3150View further author information
Pages 415-426
|
Received 05 Jun 2019, Accepted 02 Aug 2019, Published online: 19 Aug 2019
Related Research Data
Solving Differential Equations in R
Source:
The R Foundation
Transport and metabolism of cyclosporine in isolated rat hepatocytes
Source:
Elsevier BV
Simultaneous Assessment of Uptake and Metabolism in Rat Hepatocytes: A Comprehensive Mechanistic Model
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1- O -β-Glucuronide
Source:
American Chemical Society (ACS)
Cyclosporine A, but Not Tacrolimus, Shows Relevant Inhibition of Organic Anion-Transporting Protein 1B1-Mediated Transport of Atorvastatin
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Comparison of uptake transporter functions in hepatocytes in different species to determine the optimal model for evaluating drug transporter activities in humans
Source:
Informa UK Limited
A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method
Source:
Taylor & Francis
Clinical Importance of OATP1B1 and OATP1B3 in DrugDrug Interactions
Source:
Japanese Society for the Study of Xenobiotics
A mechanistic modelling approach for the determination of the mechanisms of inhibition by cyclosporine on the uptake and metabolism of atorvastatin in rat hepatocytes using a high throughput uptake method
Source:
Taylor & Francis
Structural identifiability analyses of candidate models for in vitro Pitavastatin hepatic uptake
Source:
Elsevier BV
Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes.
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Minimal output sets for identifiability
Source:
Elsevier BV
Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effect
Source:
Informa UK Limited
Identifiability of uncontrolled nonlinear rational systems
Source:
Elsevier BV
Novel In Vitro-In Vivo Extrapolation (IVIVE) Method to Predict Hepatic Organ Clearance in Rat
Source:
Springer Science and Business Media LLC
Comparison of Methods for Estimating Unbound Intracellular-to-Medium Concentration Ratios in Rat and Human Hepatocytes Using Statins
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus
Source:
Wiley
Reversible Modes of Inhibitor Interactions with Enzymes
Source:
John Wiley & Sons, Inc.
Use of Hepatocytes to Assess the Contribution of Hepatic Uptake to Clearance in Vivo
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Simultaneous Assessment In Vitro of Transporter and Metabolic Processes in Hepatic Drug Clearance: Use of a Media Loss Approach
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across species
Source:
Informa UK Limited
An Efficient Method for Structural Identifiability Analysis of Large Dynamic Systems*
Source:
Elsevier BV
Conversion to Tacrolimus and Atorvastatin in Cyclosporine-treated Heart Transplant Recipients With Dyslipidemia Refractory to Fluvastatin
Source:
Elsevier BV
Use of Mechanistic Modeling to Assess Interindividual Variability and Interspecies Differences in Active Uptake in Human and Rat Hepatocytes
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Preincubation-dependent and long-lasting inhibition of organic anion transporting polypeptide (OATP) and its impact on drug-drug interactions
Source:
Elsevier BV
Preparation of isolated rat liver cells.
Source:
Elsevier
Investigation of the Rate-Determining Process in the Hepatic Elimination of HMG-CoA Reductase Inhibitors in Rats and Humans
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Transporters as a determinant of drug clearance and tissue distribution
Source:
Elsevier BV
Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake
Source:
Informa UK Limited
Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
:{unav)
Source:
Springer Science and Business Media LLC
Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus
Source:
Wiley
Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Multiple Transporters Affect the Disposition of Atorvastatin and Its Two Active Hydroxy Metabolites: Application of in Vitro and ex Situ Systems
Source:
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model
Source:
Wiley-Blackwell
Reliability of Inhibition Models to Correctly Identify Type of Inhibition
Source:
Springer Science and Business Media LLC
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.